Peer Review History
| Original SubmissionMay 17, 2022 |
|---|
|
PONE-D-22-14260Populism and health. An evaluation of the effects of right-wing populism in the COVID-19 pandemic in BrazilPLOS ONE Dear Dr. Fernandes, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: the theme of the article is relevant, but there are already published articles showing that there were more cases of COVID-19 and higher mortality in Brazilian municipalities where JB had more votes. The article by Xavier et al. (2022), published in The Lancet Regional Health-Americas, was widely commented on in the media. Cabral et al. (2021) and Constantino et al. (2021) published other articles on this topic. Surprisingly, none of these previous studies were cited in the present article. Thus, for the present article to be considered for publication, the authors need to describe this previous research and be convincing about what the present article can add to the findings of these authors. Without this effort, the present article will be seen as "more of the same", and the conclusions that JB had more votes where there were more cases and deaths from COVID-19 are already known. ============================== Please submit your revised manuscript by Sep 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Diego Augusto Santos Silva, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a timely paper which has to be taken into consideration for publication in PLOS ONE. Authors have approached a new line of investigation in populism studies, meaning what are the effects of right-wing populism in the struggle against COVID-19 in Brasil. The findings of the paper highlight that right-wing populism is an indicator for a poor response to the COVID-19 disease. Besides the merits of the paper which are obvious, after re-reading attentively this paper I think there are several issues on which the authors have to think to revise or to improve throughout the paper. 1) In the introduction it is needed to present how this paper pushes forward the current knowledge in populism studies or what it brings new at international level of populism and coronavirus studies. So, the question that should be raised is how this study is positioned in the current broader CEE contexts or why the Brasilian case in this paper is so different from other cases we already know. These ideas can be then further connected in the last part of the paper and see how the findings of this paper differ to the previous ones in contexts of populism and coronavirus in different other countries. The theoretical background of the paper has to be a little bit improved with some recent studies on coronavirus and on the emergence of the far-right studies in different countries worldwide. First, I think some works on COVID-19 should be mentioned. There are several special issues launched at different journals on COVID-19. For instance the case of transnational migrant women in India is important, also the case of transnational workers from Romania who tried hard to work in western Europe (see a study in Eurasian Geography and Economics, 2020). Second, with connection to far-right populism there is the case of the AUR party in Romania – see Vesalon L. and Popescu L. in journal East European Politics (2022) and see Doiciar Claudia et al (2021) in Geographica Pannonica. The first paper showed how the message of AUR is similar to neo-marxists, while the second highlights how the far-right/new nationalists from AUR capitalize sensitive environmental issues in order to gain votes. Several studies on far-right in other countries of Europe should be also mentioned (see Austria, Hungary, France who have far-right parties and they were vocal during the coronavirus times, especially in connection to wearing masks, anti-vaccination protests etc). Moreover, I think that several examples of how the poor people are much easy to be influenced by the far-right discourse, because these people are more vulnerable. For instance, in Europe it is the case of the Roma people who are used by populists and far-right leaders as an electoral basin in order to win elections (see the study by Mereine Berki B. et al, 2020 in Geographica Pannonica, on how stigma against the poor Roma in Hungary can appear basing among others on historical and political manipulation of these people). The same is highlighted in an East-Central European border rural area (Romanian-Serbian) for the Roma in Romania (see a study of Covaci and Jucu, 2021 in journal Identities). 2) Methods and data interpretation are strong. Just to highlight in 1-2 sentences the limitations of the data and methods. 3) Because there is not a clear-cut discussion section in this paper, I would like to see (before the conclusions section) about 1-2 paragraphs connecting better the results of this study with the literature review on coronavirus and far-right populism. Also, some policy recommendations can be shortly addressed. 4) Conclusions should be a bit expanded by better showing the international, regional (Latin American) and Brasilian implications of this study. 5) The reference list is short, it is made up of about 20 references. I think the reference list should be made of about 50 sources. This aspect is in connection to my above point 1) where I suggested some references, but besides those examples authors have to add more references on extremism/nationalism/far-right populists in Europe, Latin America, Asia etc. Reviewer #2: [1] As a first comment, we can consider that the theme of the article is relevant, but there are already published articles showing that there were more cases of COVID-19 and higher mortality in Brazilian municipalities where JB had more votes. The article by Xavier et al. (2022), published in The Lancet Regional Health-Americas, was widely commented on in the media. Cabral et al. (2021) and Constantino et al. (2021) published other articles on this topic. Surprisingly, none of these previous studies were cited in the present article. Thus, for the present article to be considered for publication, the authors need to describe this previous research and be convincing about what the present article can add to the findings of these authors. Without this effort, the present article will be seen as "more of the same", and the conclusions that JB had more votes where there were more cases and deaths from COVID-19 are already known. Xavier, D. R., e Silva, E. L., Lara, F. A., e Silva, G. R., Oliveira, M. F., Gurgel, H., & Barcellos, C. (2022). Involvement of political and socio-economic factors in the spatial and temporal dynamics of COVID-19 outcomes in Brazil: A population-based study. The Lancet Regional Health-Americas, 100221. Cabral, S., Ito, N., & Pongeluppe, L. (2021). The disastrous effects of leaders in denial: evidence from the COVID-19 crisis in Brazil. Available at SSRN 3836147. Constantino, S. M., Cooperman, A. D., & Moreira, T. M. (2021). Voting in a global pandemic: Assessing dueling influences of Covid‐19 on turnout. Social science quarterly, 102(5), 2210-2235. [2] Some editing for English language is required throughout the manuscript due to too many mistakes. These are just a few examples found in the abstract: Change “Placebo tests indicates that” to “Placebo tests indicate that”. Change "indicator for a poor response" to "indicator of a poor response". Other weird sentences and word choices need revision. [3] The abstract should be self-explanatory, that is, the reader should be able to grasp the subject without referring to the main text. In this sense, it is not clear what "placebo tests" means in the abstract. [4] Abstract, third line. I would suggest to use “effects of the disease” or “effects of the COVID-19” rather than “effects of SARS-CoV-2”. SARS-CoV-2 refers to the virus, while COVID-19 refers to the disease that it causes in humans. [5] Introduction. It is not clear how important this sentence is in the context of the introduction: “In the past, right-wing views were represented by PSDB (Partido Social Democrata Brasileiro), a soft right-center party”. Perhaps the PSDB was closer to Tony Blair's "Third Way" vision for Europe than a far-right party, but I believe that this information is not important in the introduction of the article. [6] Introduction. The authors state that “… the effects of Bolsonarism cannot be reduced to party clues, as the president was not affiliated to any party during most part of the pandemics and changed party affiliation in the last year of his mandate”. Understanding the support that JB has from the Brazilian population requires knowledge of many factors, including religious, cultural, and social issues. Brazilian society is patriarchal and conservative, and the support for JB's ideas goes far beyond party-political issues. I believe that these articles can help the authors better structure the introduction of the article by describing the social structure of the country during the pandemic period: Farias, D. B. L., Casarões, G., & Magalhães, D. (2022). Radical right populism and the politics of cruelty: The case of COVID-19 in Brazil under President Bolsonaro. Global Studies Quarterly, 2(2), ksab048. Burity, J. (2021). The Brazilian conservative wave, the Bolsonaro administration, and religious actors. Brazilian Political Science Review, 15. Barberia, L. G., & Gómez, E. J. (2020). Political and institutional perils of Brazil's COVID-19 crisis. Lancet (London, England), 396(10248), 367. [7] Introduction. “In short, the Brazilian president disseminated the idea that COVID-19 was just a “little flu” and combating the economic crisis was more important”. I would suggest to cite this article: Dyer, O. (2020). Covid-19: Bolsonaro under fire as Brazil hides figures. BMJ, 369, m2296. [8] Introduction. In summary, the introduction section needs to be extensively reformulated in an effort to present previous articles on the topic, possible "gaps" in this research, and essential information for the reader to understand the context of the JB government's political landscape of misinformation and omission. [9] The methods section does not make clear how respiratory disease data were included in the statistical model to test for a "placebo effect." The methods section should contain enough information to ensure that readers can reproduce the statistical analyses. [10] In the conclusion section, the authors argue that the "Findings show that the impact of extreme right-wing views on the pandemic has been striking in Brazil". However, in the introduction of the article, the authors discuss that "In the Brazilian case, however, party connections are less relevant, as the president was not a member of any party throughout the first and second wave of the pandemic". I think that these sentences are contradictory in some ways. It does not appear that right-wing views are related to the number of COVID-19 cases or deaths, but these relationships are determined by a wide range of issues, including traditional, conservative, religious views, and even a sense of Brazilian Mccarthyism that demonizes perceived "left-wing" social actions. So the problem does not seem to be that JB is a right-wing politician, but what causes greater numbers of the disease is his populism and conservative views of the population. [11] I have doubt that the statistical methods used by the authors are the most appropriate for the data. The authors do not comment on model assumptions, such as the linearity of the relationship between independent and dependent variables, and the diagnosis of homoscedasticity and distribution of residuals. The model does not include an offset variable or a population size weighting strategy. The model also does not include spatial structures that would allow testing on maps for clusters where JB has more votes and COVID-19 cases were more frequent. The previous papers by Xavier et al. (2022), Cabral et al. (2021), and Constantino et al. (2021) show maps and graphs, which are more understandable than the results shown in the present study. [12] Potential limitations of the study are not presented. [13] The discussion section is very shallow and it needs major modification. [14] At the end of the article, the sentence beginning with “Lastly, an important research topic on the effects of populism…” needs some revision, and this argument could be supported by the following articles: Daniels, J. P. (2021). Health experts slam Bolsonaro's vaccine comments. The Lancet, 397(10272), 361. Boschiero, M. N., Palamim, C. V. C., & Marson, F. A. L. (2021). COVID-19 vaccination on Brazil and the crocodile side-effect. Ethics, medicine, and public health, 17, 100654. Reviewer #3: This paper is very well-written and provides an excellent combination of theory on populism and evidence surrounding subnational responses to the covid-19 pandemic in Brazil. I have several recommendations that I think will improve the overall contribution, which I already find compelling. First, I suggest adding a “limitations” section along the lines of what we’ve seen recently in many public health and medical journal publications surrounding covid-19. Most of these limitations are methodological, which I think is completely acceptable given the real-time data collection and analysis in question. causal identification is very difficult in this context, which I think is reasonable and currently common in the top medical journals for work on covid. However, I suggest moderating some of the claims in the paper and describing why the models presented represent the best-case scenario in the current climate and how the results can still help build theory and inform government practice. Another limitation is simply the lack of municipal level covariates available and/or the way that aggregating to the municipal level obscures unobserved and (probably) unobservable submunicipal variation. Next, I suggest defending the case selection a little more thoroughly. For example, are the results from Brazil generalizable beyond the country? Why/why not? I agree with the authors’ rationale and I think they should make an even larger claim: that brazil, due to data availability and municipal variation, is the only country where they could plausibly test hypotheses against such broad, deep data. Defending the particular timeframe under consideration should also be part of the next revision. I see lots of reasons to focus on the timeframe under consideration in the article, but I would like to see those reasons articulated thoroughly. For example, because the covid response shifted from NPIs to vaccines after 2020. Finally, there is recent literature on Brazil and Mexico and on subnational covid issues in Latin America in general that should be included in the review and with which this article can enter into conversation: Knaul, F. M., Touchton, M., Arreola-Ornelas, H., Atun, R., Anyosa, R. J. C., Frenk, J., ... & Victora, C. (2021). Punt politics as failure of health system stewardship: evidence from the COVID-19 pandemic response in Brazil and Mexico. The Lancet Regional Health-Americas, 4, 100086. Touchton, Michael, Felicia Marie Knaul, Héctor Arreola-Ornelas, Thalia Porteny, Mariano Sánchez, Oscar Méndez, Marco Faganello et al. "A partisan pandemic: state government public health policies to combat COVID-19 in Brazil." BMJ global health 6, no. 6 (2021): e005223. Knaul, F. M., Touchton, M. M., Arreola-Ornelas, H., Calderon-Anyosa, R., Otero-Bahamón, S., Hummel, C., ... & Sanchez-Talanquer, M. (2022). Strengthening Health Systems To Face Pandemics: Subnational Policy Responses To COVID-19 In Latin America: Study examines policy responses to COVID-19 in Latin America. Health Affairs, 41(3), 454-462. Testa, Paul F., Richard Snyder, Eva Rios, Eduardo Moncada, Agustina Giraudy, and Cyril Bennouna. "Who Stays at Home? The Politics of Social Distancing in Brazil, Mexico, and the United States during the COVID-19 Pandemic." Journal of Health Politics, Policy and Law (2021). Castro, Marcia C., Sun Kim, Lorena Barberia, Ana Freitas Ribeiro, Susie Gurzenda, Karina Braga Ribeiro, Erin Abbott, Jeffrey Blossom, Beatriz Rache, and Burton H. Singer. "Spatiotemporal pattern of COVID-19 spread in Brazil." Science 372, no. 6544 (2021): 821-826. Knaul, Felicia, Héctor Arreola-Ornelas, Thalia Porteny, Michael Touchton, Mariano Sánchez-Talanquer, Óscar Méndez, Salomón Chertorivski et al. "Not far enough: Public health policies to combat COVID-19 in Mexico’s states." Plos one 16, no. 6 (2021): e0251722. The rest of the paper is very well-done. By engaging with the recent literature on the speicifc subject, the paper will be easier to find for scholars and policymakers working in the area. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Populism and health. An evaluation of the effects of right-wing populism on the COVID-19 pandemic in Brazil PONE-D-22-14260R1 Dear Dr. Fernandes, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Diego Augusto Santos Silva, Ph.D. Academic Editor PLOS ONE Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #3: I am satisfied with the revised submission- all comments have been addressed and I recommend acceptance for publication ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-22-14260R1 Populism and health. An evaluation of the effects of right-wing populism on the COVID-19 pandemic in Brazil Dear Dr. Fernandes: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Diego Augusto Santos Silva Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .